|
|
| [Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index] |
FDA News Digest
March 31, 2008
_____________________________________
IN THIS WEEK'S ISSUE
» News
-- Recommendations Made on Devices That Treat Blocked Heart Arteries
» Consumer Health Information
Recommendations Made on Devices That Treat Blocked Heart Arteries FDA has issued draft guidelines to aid the development, testing and manufacture of coronary drug-eluting stents, which are devices used to treat blocked heart arteries. FDA and the clinical community have been closely monitoring these devices, including concerns over clot formation in some patients several years after implantation. The draft guidelines outline the agency's recommendations for providing data to better address the clot issue and other potential safety concerns.
http://www.fda.gov/bbs/topics/NEWS/2008/NEW01810.html 25 Drugs, Biologics Identified for Safety Plan Requirements
FDA has identified 25 drugs and biologic products that will be required to submit safety plans called Risk Evaluation and Mitigation Strategy (REMS). FDA can require manufacturers to submit a REMS when a drug first comes on the market or later if FDA becomes aware of new safety data about the drug. Manufacturers of the 25 drugs and biologic products identified in today's notice must submit to the agency a proposed REMS by Sept. 21, 2008. FDA Seeks Civil Penalties from FDA is seeking a $2.2 million penalty against To access the RSS feed of FDA news releases, go to http://www.fda.gov/bbs/topics/news/rssPress.xml. [What is an RSS feed? See http://www.fda.gov/bbs/topics/news/newsfeeds.html.]
_____________________________________________
SAFETY ALERTS/RECALLS
Safety Alerts:
› FDA is advising consumers not to buy or use "Blue Steel" or "Hero" products, marketed as dietary supplements throughout the United States, because they are considered unapproved drugs and have not been proven to be safe or effective. These products contain undeclared ingredients, which may dangerously affect blood pressure level. They are promoted and sold over the Internet for the treatment of erectile dysfunction (ED) and for sexual enhancement. They are labeled as dietary supplements but do not qualify as such because they contain undeclared and unapproved substances similar in chemical structure to sildenafil, the active ingredient in the ED drug Viagra. http://www.fda.gov/bbs/topics/NEWS/2008/NEW01809.html
› FDA also is advising consumers not to buy or consume Total Body Formula in the flavors of Tropical Orange and Peach Nectar, or Total Body Mega Formula in the Orange/Tangerine flavor. The liquid dietary supplement products may cause severe adverse reactions, including significant hair loss, muscle cramps, diarrhea, joint pain and fatigue. Food Recalls:
› Honduran Cantaloupes grown by Agropecuaria Montelibano
Reason for recall: Salmonella contamination
› Certain batches of Stonyfield Organic Fat Free Blueberry Yogurt, 6-oz. cups
Reason for recall: reported plastic or glass fragments in product
http://www.fda.gov/oc/po/firmrecalls/stonyfield03_08.html products from the past 60 days, go to http://www.fda.gov/opacom/7alerts.html.
To access the RSS feed of FDA recalls information, go to http://www.fda.gov/oc/po/firmrecalls/rssRecalls.xml
[What is an RSS feed? See http://www.fda.gov/bbs/topics/news/newsfeeds.html.]
____________________________________________________________________
UPCOMING PUBLIC MEETINGS
April 1-2 -- Anti-Infective Drugs Advisory Committee Under discussion: product development and clinical trial design for community-acquired pneumonia Location: http://www.fda.gov/OHRMS/DOCKETS/98fr/E8-814.htm
Location: Dallas, Texas
http://www.fda.gov/OHRMS/DOCKETS/98fr/E7-20077.htm
April 7-8 -- QT and Arrhythmia Issues in Drug Development
Under discussion: development of pharmaceutical agents, as well as challenges and solutions
Location: Bethesda, Md.
April 10-11 -- Cellular, Tissue and Gene Therapies Advisory Committee
Under discussion: safety testing for cellular therapy products derived from human embryonic stem cells
Location: Gaithersburg, Md.
For a complete list of meetings, seminars, and other public events sponsored or co-sponsored by FDA, go to http://www.fda.gov/opacom/hpmeetings.html.
http://www.fda.gov/consumer/updates/ultrasound032408.html
› Avoid Fetal “Keepsake” Images, Heartbeat Monitors http://www.fda.gov/consumer/updates/keepsakevideo032408.html To receive all consumer updates, go to http://www.fda.gov/consumer/consumerenews.html
Thanks for subscribing to FDA News Digest.
Comments about FDA News Digest?
Send an e-mail to fdanewsdigest@xxxxxxxxxv.
Update your subscriptions, modify your e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact support@xxxxxxxxxxxxxxx.
This service is provided to you at no charge by U.S. Food & Drug Administration (FDA).
GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420
[Books] [Home] [CDC News] [NIH News] [USDA News] [Photo] [Yosemite News] [Hot Springs] [Steve's Art] [Yosemite Photos] [PhotoForum] [SB Lupus] [Science Toys] [STB]
![]() |
![]() |